EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
This 2010 guideline by the European Federation of Neurological Societies (EFNS) offers evidence-based recommendations for diagnosing and managing European Lyme neuroborreliosis (LNB). It emphasizes clinical assessment supported by cerebrospinal fluid (CSF) analysis, including pleocytosis and intrathecal Borrelia-specific antibody production. The guidelines recommend intravenous ceftriaxone (2 g/day for 14 days) as